Pharmaceuticals by one-year price change
How far the share price has moved over the last 52 weeks.
Erasca leads the 61 pharmaceuticals ranked by one-year price change, at +403%, ahead of Spyre Therapeutics (+286%) and Oruka Therapeutics (+241%). Figures as of 18 Nov 2026, 15:06 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Erasca+403%
- Median
- +26.9%
- Combined market value
- NOK 49.71T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | 1 year ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ErascaERAS · Health Care | +403% | NOK 46.1B | NOK 131.28 | 2.48% down | 403% up | ||
| 2 | Spyre TherapeuticsSYRE · Health Care | +286% | NOK 88.3B | NOK 930.27 | 2.31% up | 286% up | ||
| 3 | Oruka TherapeuticsORKA · Health Care | +241% | NOK 64.4B | NOK 949.95 | 1.75% up | 241% up | ||
| 4 | VeradermicsMANE · Health Care | +233% | NOK 51.9B | NOK 1,229.19 | 0.94% up | 233% up | ||
| 5 | Definium TherapeuticsDFTX · Health Care | +169% | NOK 39.2B | NOK 286.36 | 0.56% up | 169% up | ||
| 6 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | +126% | NOK 73.6B | NOK 936.38 | 1.58% up | 126% up | ||
| 7 | Dianthus TherapeuticsDNTH · Health Care | +113% | NOK 48B | NOK 852.64 | 1.14% up | 113% up | ||
| 8 | TG TherapeuticsTGTX · Health Care | +107% | NOK 93.7B | NOK 619.73 | 1.96% up | 107% up | ||
| 9 | ViatrisVTRS · Health Care | +95.5% | NOK 230B | NOK 200.58 | 1.20% up | 96% up | ||
| 10 | Roivant SciencesROIV · Health Care | +90.3% | NOK 274.9B | NOK 379.36 | 1.11% up | 90% up | ||
| 11 | Edgewise TherapeuticsEWTX · Health Care | +88.2% | NOK 44.1B | NOK 402.96 | 1.11% down | 88% up | ||
| 12 | Amneal PharmaceuticalsAMRX · Health Care | +83.3% | NOK 72.7B | NOK 208.58 | 1.89% up | 83% up | ||
| 13 | Royalty PharmaRPRX · Health Care | +77.7% | NOK 383.9B | NOK 667.61 | 0.29% up | 78% up | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | +74.4% | NOK 484.8B | NOK 415.51 | 0.59% up | 74% up | ||
| 15 | GenmabGMAB · Health Care | +70.0% | NOK 309B | NOK 501.10 | 0.50% down | 70% up | ||
| 16 | Praxis Precision MedicinesPRAX · Health Care | +61.1% | NOK 84.2B | NOK 3,013.45 | 1.92% up | 61% up | ||
| 17 | AlkermesALKS · Health Care | +58.4% | NOK 75.5B | NOK 449.29 | 1.99% up | 58% up | ||
| 18 | Takeda PharmaceuticalTAK · Health Care | +53.6% | NOK 666.1B | NOK 208.48 | 0.60% down | 54% up | ||
| 19 | Merck & CoMRK · Health Care | +50.8% | NOK 3.38T | NOK 1,371.66 | 1.29% down | 51% up | ||
| 20 | Protagonist TherapeuticsPTGX · Health Care | +46.4% | NOK 79.7B | NOK 1,221.00 | 1.05% up | 46% up | ||
| 21 | Travere TherapeuticsTVTX · Health Care | +44.2% | NOK 47.2B | NOK 492.11 | 0.64% down | 44% up | ||
| 22 | Ligand PharmaceuticalsLGND · Health Care | +42.6% | NOK 57.5B | NOK 2,872.62 | 0.87% up | 43% up | ||
| 23 | Johnson & JohnsonJNJ · Health Care | +37.6% | NOK 6.47T | NOK 2,686.05 | 0.56% down | 38% up | ||
| 24 | Jazz PharmaceuticalsJAZZ · Health Care | +36.7% | NOK 151.1B | NOK 2,353.65 | 0.88% up | 37% up | ||
| 25 | Regeneron PharmaceuticalsREGN · Health Care | +36.3% | NOK 964.3B | NOK 9,321.93 | 0.42% up | 36% up | ||
| 26 | Eli LillyLLY · Health Care | +34.9% | NOK 12.1T | NOK 13,585.75 | 0.98% down | 35% up | ||
| 27 | Bristol-Myers SquibbBMY · Health Care | +34.0% | NOK 1.2T | NOK 587.99 | 1.12% down | 34% up | ||
| 28 | Belite BioBLTE · Health Care | +31.0% | NOK 62.2B | NOK 1,530.82 | 0.14% up | 31% up | ||
| 29 | Mirum PharmaceuticalsMIRM · Health Care | +30.5% | NOK 58.2B | NOK 891.84 | 0.07% up | 31% up | ||
| 30 | Ascendis PharmaASND · Health Care | +27.8% | NOK 172.5B | NOK 2,629.06 | 0.02% up | 28% up | ||
| 31 | Vertex PharmaceuticalsVRTX · Health Care | +26.9% | NOK 1.33T | NOK 5,246.46 | 1.33% up | 27% up | ||
| 32 | AbbVieABBV · Health Care | +25.7% | NOK 4.99T | NOK 2,820.24 | 0.63% down | 26% up | ||
| 33 | NovartisNVS · Health Care | +25.0% | NOK 2.88T | NOK 1,524.61 | 1.15% down | 25% up | ||
| 34 | United TherapeuticsUTHR · Health Care | +22.6% | NOK 239.6B | NOK 5,625.40 | 0.63% down | 23% up | ||
| 35 | Elanco Animal HealthELAN · Health Care | +20.5% | NOK 127.5B | NOK 255.10 | 1.82% up | 20% up | ||
| 36 | BridgeBio PharmaBBIO · Health Care | +17.2% | NOK 146.8B | NOK 753.68 | 1.25% up | 17% up | ||
| 37 | BeOne MedicinesONC · Health Care | +16.8% | NOK 449.9B | NOK 3,938.74 | 1.67% down | 17% up | ||
| 38 | PfizerPFE · Health Care | +14.4% | NOK 1.56T | NOK 274.34 | 0.58% down | 14% up | ||
| 39 | Rhythm PharmaceuticalsRYTM · Health Care | +13.0% | NOK 78.2B | NOK 1,127.56 | 0.24% down | 13% up | ||
| 40 | BioMarin PharmaceuticalBMRN · Health Care | +11.3% | NOK 111.3B | NOK 574.85 | 1.37% up | 11% up | ||
| 41 | Arrowhead PharmaceuticalsARWR · Health Care | +10.3% | NOK 59.9B | NOK 423.56 | 1.65% up | 10% up | ||
| 42 | GSKGSK · Health Care | +6.26% | NOK 954.9B | NOK 476.38 | 0.18% down | 6% up | ||
| 43 | Dr. Reddy's LaboratoriesRDY · Health Care | +5.27% | NOK 121B | NOK 145.14 | 1.18% up | 5% up | ||
| 44 | AstraZenecaAZN · Health Care | +2.41% | NOK 2.71T | NOK 1,748.60 | 1.02% down | 2% up | ||
| 45 | GrifolsGRFS · Health Care | +1.41% | NOK 56.7B | NOK 83.35 | 0.35% down | 1% up | ||
| 46 | SanofiSNY · Health Care | -4.08% | NOK 1.11T | NOK 460.97 | 0.06% up | 4% down | ||
| 47 | Axsome TherapeuticsAXSM · Health Care | -7.37% | NOK 68.8B | NOK 1,308.47 | 0.70% down | 7% down | ||
| 48 | Corcept TherapeuticsCORT · Health Care | -7.92% | NOK 74.3B | NOK 679.29 | 0.02% up | 8% down | ||
| 49 | Novo NordiskNVO · Health Care | -16.9% | NOK 1.72T | NOK 389.54 | 1.25% down | 17% down | ||
| 50 | Abbott LaboratoriesABT · Health Care | -17.0% | NOK 1.76T | NOK 1,016.44 | 0.15% up | 17% down | ||
| 51 | PTC TherapeuticsPTCT · Health Care | -20.2% | NOK 49.1B | NOK 587.55 | 0.43% up | 20% down | ||
| 52 | CytokineticsCYTK · Health Care | -20.3% | NOK 71B | NOK 509.53 | 1.78% up | 20% down | ||
| 53 | Cogent BiosciencesCOGT · Health Care | -20.3% | NOK 47.8B | NOK 274.78 | 1.80% up | 20% down | ||
| 54 | Madrigal PharmaceuticalsMDGL · Health Care | -24.0% | NOK 94.7B | NOK 4,074.67 | 0.38% down | 24% down | ||
| 55 | ABIVAXABVX · Health Care | -27.3% | NOK 71.2B | NOK 813.82 | 2.27% up | 27% down | ||
| 56 | ZoetisZTS · Health Care | -28.7% | NOK 329.8B | NOK 811.64 | 0.31% up | 29% down | ||
| 57 | Summit TherapeuticsSMMT · Health Care | -35.6% | NOK 87.6B | NOK 109.55 | 5.93% up | 36% down | ||
| 58 | InsmedINSM · Health Care | -40.1% | NOK 259.3B | NOK 1,181.79 | 0.06% up | 40% down | ||
| 59 | Legend BiotechLEGN · Health Care | -42.5% | NOK 30.9B | NOK 159.25 | 1.99% up | 42% down | ||
| 60 | Ionis PharmaceuticalsIONS · Health Care | -63.6% | NOK 44.2B | NOK 265.47 | 1.59% up | 64% down | ||
| 61 | Alnylam PharmaceuticalsALNY · Health Care | -66.0% | NOK 202.5B | NOK 1,512.16 | 0.31% down | 66% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 9.6924 NOK).
Questions and answers
Which pharmaceuticals rank first by one-year price change?
Erasca (+403%), Spyre Therapeutics (+286%) and Oruka Therapeutics (+241%) are the top three of the 61 pharmaceuticals ranked by one-year price change as of 18 Nov 2026, 15:06 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by one-year price change.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by one-year price change have a combined market value of NOK 49.71T as of 18 Nov 2026, 15:06 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Pharmaceuticals by one-year price change”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.